rabbit polyclonal antibodies against ampk α1 (Proteintech)
Structured Review

Rabbit Polyclonal Antibodies Against Ampk α1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 189 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibodies against ampk α1/product/Proteintech
Average 96 stars, based on 189 article reviews
Images
1) Product Images from "3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5"
Article Title: 3-Bromopyruvate sensitizes human breast cancer cells to TRAIL-induced apoptosis via the phosphorylated AMPK-mediated upregulation of DR5
Journal: Oncology Reports
doi: 10.3892/or.2018.6644
Figure Legend Snippet: 3-BP induces AMPK phosphorylation and induces cell death. (A) The levels of CHOP, GRP78, AMPK-α and p-AMPK were detected in breast cancer MCF-7 and MDA-MB-231 cells treated with 3-BP (0, 40, 80 and 160 µmol/l) for 24 h via western blot analysis. (B) The expression levels of Bax in MCF-7 cells and caspase-3 protein in MDA-MB-231 cells were detected via western blotting in cells treated with 80 µmol/l 3-BP and 200 ng/ml TRAIL. 3-BP, 3-bomopyruvate.
Techniques Used: Phospho-proteomics, Western Blot, Expressing
Figure Legend Snippet: The AMPK inhibitor Compound C attenuates the effects of 3-BP on breast cancer cells. MCF-7 and MDA-MB-231 cells were treated with 1 µmol/l Compound C (Com C), 80 µmol/l 3-BP, and 200 ng/ml TRAIL, or both 3-BP and TRAIL, as indicated. (A) Cell viability was determined using an MTT assay. (B) Cell morphology was examined via light microscopy and apoptosis rate was determined using the PI staining method and flow cytometry. Data are expressed as the mean ± standard error of the mean (n=3). TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; 3-BP, 3-bomopyruvate.
Techniques Used: MTT Assay, Light Microscopy, Staining, Flow Cytometry
Figure Legend Snippet: AMPK induces ER stress and sensitizes breast cancer cells to TRAIL in response to treatment with 3-BP. (A) Cells treated with medium (Control), 1 µmol/l Compound C (Com C) or Compound C combined with 80 µmol/l 3-BP for 24 h were investigated via flow cytometry. (B) MCF-7 and MDA-MB-231 cells pre-treated with 1 µmol/l Compound C for 1 h were subsequently treated with 0, 40, 80 or 160 µmol/l 3-BP for 24 h. The expression levels of AMPK, GRP78, CHOP and DR5 were investigated with western blotting. (C) Cells pre-treated with or without 1 µmol/l Compound C for 1 h, were treated with medium, Compound C, 80 µmol/l 3-BP, 200 ng/ml TRAIL or both 3-BP and TRAIL, as indicated, for 24 h. The expression levels of Bax and Bcl-2 were determined in MCF-7 cells and caspase-3 was investigated in the MDA-MB-231 cells by western blotting. β-actin served as loading control. TRAIL, tumor necrosis factor-related apoptosis-inducing ligand; 3-BP, 3-bomopyruvate; DR5, death receptor 5.
Techniques Used: Control, Flow Cytometry, Expressing, Western Blot